Corticosteroids for treating hypotension in preterm infants.

Area of Science:

• Neonatalogy
• Pediatric Pharmacology

Background:

• Systemic hypotension is a common complication in preterm infants, linked to adverse neurodevelopmental outcomes.
• Corticosteroids are explored as an alternative or adjunct to conventional hypotension treatments.

Purpose of the Study:

• To assess the effectiveness and safety of corticosteroids for treating hypotension in preterm infants.
• To evaluate corticosteroids as primary treatment or for refractory hypotension.

Main Methods:

• Systematic review of randomized or quasi-randomized controlled trials.
• Included studies on preterm infants (<37 weeks gestation) with hypotension, comparing corticosteroids to placebo, other drugs, or no therapy.
• Assessed methodological quality and analyzed data using standard meta-analysis methods.

Main Results:

• Two studies with 57 infants were included.
• Hydrocortisone showed no significant difference compared to dopamine for primary hypotension.
• Dexamethasone appeared effective for refractory hypotension but lacked long-term safety data.

Conclusions:

• Insufficient evidence supports routine corticosteroid use for neonatal hypotension.
• Dexamethasone may be effective for refractory hypotension, but long-term safety concerns preclude routine recommendation.
• Further research is needed on the long-term safety and efficacy of corticosteroids in preterm infants.